ePrints

Congenital anomalies after prenatal ecstasy exposure

Lookup NU author(s): Dr Patricia McElhatton, Professor Simon ThomasORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15.4% [95% CI 8.2-25.4]). Cardiovascular anomalies (26 per 1000 livebirths [3.0-90.0]) and musculoskeletal anomalies (38 per 1000 [8.0-109.0]) were predominant.

Publication metadata

Author(s): McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SHL

Publication type: Article

Publication status: Published

Journal: The Lancet

Year: 1999

Volume: 354

Issue: 9188

Pages: 1441-1442

Print publication date: 23/10/1999

ISSN (print): 0140-6736

ISSN (electronic): 1474-547X

Publisher: The Lancet Publishing Group

URL: http://dx.doi.org/10.1016/S0140-6736(99)02423-X

DOI: 10.1016/S0140-6736(99)02423-X

PubMed id: 10543673

Altmetrics

Share